Longevity clinic at Bumrungrad Hospital adopts proteomics take a look at that predicts sufferers’ present and future threat of a number of persistent ailments.
Japanese expertise big NEC has revealed that its FonesVisuas blood take a look at has been adopted by the VitalLife longevity clinic at Bumrungrad Worldwide Hospital in Bangkok, Thailand. The take a look at evaluates 1000’s of proteins from a single blood pattern to visualise a person’s present and future well being standing and dangers for ailments, together with dementia, coronary heart assault, lung most cancers and persistent kidney illness.
Constantly acknowledged as one of many world’s greatest hospitals, Bumrungrad is understood for its early adoption of superior medical applied sciences. The hospital’s VitalLife middle is concentrated on personalised healthcare and longevity, integrating cutting-edge expertise and biomarkers to detect potential well being dangers and apply personalised interventions promptly.
VitalLife’s adoption of the FonesVisuas take a look at goals to reinforce the clinic’s potential to foretell sufferers’ threat of illness by analyzing modifications in proteins. Powered by the SomaScan Platform from proteomics firm SomaLogic, the FonesVisuas take a look at supplies intensive insights into protein biology and interactions by measuring greater than 7,000 proteins concurrently from a single pattern.
The VitalLife deployment is the primary deployment of the FonesVisuas take a look at exterior Japan, and NEC now plans to develop its provision internationally, significantly within the Asia-Pacific area.
